ArticleFrontiers in oncology2020

Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer.

Xin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.